ConductScience.org, home

Paper37366237

Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease.

Liu Q and 6 others. EMBO J, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease. Papers, record 37366237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37366237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease.
PubMed
Journal
EMBO J
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2026-01-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
Animals
Mice
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Protein Serine-Threonine Kinases
RNA Stability
RNA, Messenger
Mutation
Aminoimidazole Carboxamide
Ribonucleotides

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 AG046366NIA NIH HHSUnited StatesK01AG046366PubMed and NIHNIH RePORTER
R01 GM136904NIGMS NIH HHSUnited StatesR01GM136904PubMed and NIHNIH RePORTER
R01 NS112506NINDS NIH HHSUnited StatesR01NS112506PubMed and NIHNIH RePORTER
R01 GM136904NIGMS NIH HHSUnited StatesR01GM136904PubMed and NIHNIH RePORTER
R01 NS112506NINDS NIH HHSUnited StatesR01NS112506PubMed and NIHNIH RePORTER
K01 AG046366NIA NIH HHSUnited StatesK01AG046366PubMed and NIHNIH RePORTER

Download CSV of grants

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128649611LRRK2 levels in immune cells are increased in Parkinson's disease.NPJ Parkinsons Dis2017https://conductscience.org/library/papers/28649611PubMed
218258746A Drosophila model for LRRK2-linked parkinsonism.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18258746PubMed
333454605Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease.Parkinsonism Relat Disord2021https://conductscience.org/library/papers/33454605PubMed
421859862c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies.J Cell Biol2011https://conductscience.org/library/papers/21859862PubMed
519536328Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP.PLoS One2009https://conductscience.org/library/papers/19536328PubMed
634064363AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review.Cells2021https://conductscience.org/library/papers/34064363PubMed
727911006LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.Mov Disord2017https://conductscience.org/library/papers/27911006PubMed
827658356Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation.Sci Rep2016https://conductscience.org/library/papers/27658356PubMed
923967090Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.PLoS One2013https://conductscience.org/library/papers/23967090PubMed
1020041156The WD40 domain is required for LRRK2 neurotoxicity.PLoS One2009https://conductscience.org/library/papers/20041156PubMed
1134439767LRRK2 Targeting Strategies as Potential Treatment of Parkinson's Disease.Biomolecules2021https://conductscience.org/library/papers/34439767PubMed
1211689683Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate.Mol Cell Biol2001https://conductscience.org/library/papers/11689683PubMed
136150139An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids.Lancet1984https://conductscience.org/library/papers/6150139PubMed
1435637059Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.Brain Dev2022https://conductscience.org/library/papers/35637059PubMed
1535675433Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.Sci Transl Med2022https://conductscience.org/library/papers/35675433PubMed
1677440805-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?Eur J Biochem1995https://conductscience.org/library/papers/7744080PubMed
1715114530AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.Am J Hum Genet2004https://conductscience.org/library/papers/15114530PubMed
1821603177Lipopolysaccharide animal models for Parkinson's disease.Parkinsons Dis2011https://conductscience.org/library/papers/21603177PubMed
1932557644AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case.J Inherit Metab Dis2020https://conductscience.org/library/papers/32557644PubMed
2019196961CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19196961PubMed

See all 74 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42588185Alterations in Gut Microbiota and Serum Metabolome Are Associated with Postpartum Depression.Nutrients2026https://conductscience.org/library/papers/42588185PubMed
42477458Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.Oncogene2026https://conductscience.org/library/papers/42477458PubMed
42470822Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.Pharmacol Rev2026https://conductscience.org/library/papers/42470822PubMed
41226290Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement.Int J Mol Sci2025https://conductscience.org/library/papers/41226290PubMed
41194937CircUBAP2(9,12) Inhibits Nasopharyngeal Carcinoma Invasion and Metastasis by Down-regulating ZEB2 through Competitive Binding to AUF1.Research (Wash D C)2025https://conductscience.org/library/papers/41194937PubMed
40076730LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson's Disease.Int J Mol Sci2025https://conductscience.org/library/papers/40076730PubMed
39705401In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's disease.Brain2025https://conductscience.org/library/papers/39705401PubMed
39576856CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration.Sci Adv2024https://conductscience.org/library/papers/39576856PubMed
39153957LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.Trends Mol Med2024https://conductscience.org/library/papers/39153957PubMed
37697064Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production.Oncogene2023https://conductscience.org/library/papers/37697064PubMed
37366237Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease.EMBO J2023https://conductscience.org/library/papers/37366237PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LRRK2120892PubTator's text mininghttps://conductscience.org/library/genes/120892

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37366237

GET https://conductscience.org/api/papers/v1/37366237/references?page=2